Statistics

Total Visits

Views
CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP50

Select a period of time:

Number of views in the range

Views
CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP26

Views

Views
May 20251
June 20252
July 202516
August 20252
September 20253
October 20251
November 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil7
Turkey3
Canada2
Ecuador1
United Kingdom1
South Korea1
Mexico1
Paraguay1
South Africa1
 

Top cities views

Views
Ankara1
Arapiraca1
Asunción1
Bridgewater1
Brooklyn1
Campos dos Goytacazes1
Cincinnati1
Guarulhos1
Guayaquil1
Jequié1